Genetic Diseases Inborn
📧 Sign up to get email alerts when something new happens for Genetic Diseases Inborn.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2024-03-14EMA Application withdrawn: Vijoice (alpelisib) — Novartis Europharm Limited
The EMA has withdrawn the application for Vijoice (alpelisib) from Novartis Europharm Limited for genetic diseases and growth disorders.